Look forward to seeing more of the read-out results. Obviously the early ones have been good. Bell Potter picked this and VLA as the best / most advanced. Should see the price move ahead as further de-risking occurs and CE gets closer. Should at least move closer to the current 12 month target prices near $0.40.
Sure will raise, but will likely be higher and there should be pretty good appetite now and another de-risking. Many failed underbidders for SRX and OSL can move into first line in liver, not just pancreas.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.010(0.92%) |
Mkt cap ! $20.70M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.12 | $1.08 | $7.167K | 6.578K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 779 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 1400 | 1 |
View Market Depth
| Last trade - 14.23pm 11/08/2025 (20 minute delay) ? |
| OSL (ASX) Chart |